These are Monday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls:
Baidu, Inc. (NASDAQ: BIDU) Raised to Neutral at Credit Suisse.
Calpine Corp. (NYSE: CPN) Raised to Equal Weight at Barclays.
L-1 Identity Solutions (NYSE: ID) Cut to Underweight at JPMorgan.
Macy’s Inc. (NYSE: M) Cut to Hold at Deutsche Bank.
Mirant Corporation (NYSE: MIR) Cut to Underweight at Barclays.
Omnicall Inc. (NASDAQ: OMCL) Raised to Buy at ThinkEquity.
ProLogis (NYSE: PLD) Raised to Neutral at UBS.
RF Micro Devices (NASDAQ: RFMD) Started as Buy at Merriman Curhan Ford.
RRI Energy, Inc. (NYSE: RRI) Cut to Equal Weight at Barclays.
Salix Pharmaceuticals (NASDAQ: SLXP) Started as Buy at Jefferies.
Time Warner Inc. (NYSE: TWX) Raised to Buy at Benchmark.
Vertex Pharmaceuticals (NASDAQ: VRTX) Raised to Outperform at Oppenheimer.
You are invited to join our free daily email distribution list to hear about top analyst upgrades and downgrades, IPOs and secondary offerings, ongoing day trader and options trader alerts, stock and market rumors, Buffett and guru investor news, M&A and more.
JON C. OGG
FEBRUARY 1, 2010
RSS Updates
Email Updates



The offer from NRG Energy, Inc. (NYSE:NRG) to buy the retail business of Reliant Energy Inc. (NYSE:RRI) for $287.5 million has now drawn some attention from Fitch Ratings. As one might expect, the benefits to Reliant outweigh the benefits to NRG, at least that’s what Fitch thinks.
Reliant Energy Inc. (NYSE: RRI) is taking a hit this morning. It wasn’t just the earnings loss, or its plans to sell a unit. This really appears to be over the ramifications of the long-term aspects colliding with the near term aspects. The company suddenly finds itself nestled inside this merger fight between NRG Energy, Inc. (NYSE: NRG) and Exelon Corporation (NYSE: EXC).





